======= SEC24A ======= == Gene Information == * **Official Symbol**: SEC24A * **Official Name**: SEC24 homolog A, COPII coat complex component * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=10802|10802]] * **UniProt**: [[https://www.uniprot.org/uniprot/O95486|O95486]] * **Interactions**: [[https://thebiogrid.org/search.php?search=SEC24A&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20SEC24A|Open PubMed]] * **OMIM**: [[https://omim.org/entry/607183|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Component of the coat protein complex II (COPII) which promotes the formation of transport vesicles from the endoplasmic reticulum (ER). The coat has two main functions, the physical deformation of the endoplasmic reticulum membrane into vesicles and the selection of cargo molecules for their transport to the Golgi complex (PubMed:20427317, PubMed:17499046, PubMed:18843296). Plays a central role in cargo selection within the COPII complex and together with SEC24B may have a different specificity compared to SEC24C and SEC24D. May package preferentially cargos with cytoplasmic DxE or LxxLE motifs and may also recognize conformational epitopes (PubMed:17499046, PubMed:18843296). {ECO:0000269|PubMed:17499046, ECO:0000269|PubMed:18843296, ECO:0000269|PubMed:20427317}. |Sec23 BS| |Gelsolin| |Sec23 trunk| |zf-Sec23 Sec24| |Sec23 helical| |regulation of low-density lipoprotein particle receptor biosynthetic process| |COPII-coated vesicle cargo loading| |COPII vesicle coat| |regulation of receptor biosynthetic process| |vesicle cargo loading| |ER to Golgi transport vesicle membrane| |vesicle targeting, rough ER to cis-Golgi| |COPII vesicle coating| |vesicle coating| |COPII-coated vesicle budding| |vesicle targeting, to, from or within Golgi| |Golgi vesicle budding| |cholesterol homeostasis| |sterol homeostasis| |localization within membrane| |vesicle targeting| |vesicle budding from membrane| |antigen processing and presentation of peptide antigen via MHC class I| |antigen processing and presentation of exogenous peptide antigen via MHC class II| |antigen processing and presentation of peptide or polysaccharide antigen via MHC class II| |antigen processing and presentation of peptide antigen via MHC class II| |lipid homeostasis| |establishment of vesicle localization| |antigen processing and presentation of exogenous peptide antigen| |antigen processing and presentation of exogenous antigen| |vesicle localization| |antigen processing and presentation of peptide antigen| |endoplasmic reticulum to Golgi vesicle-mediated transport| |antigen processing and presentation| |positive regulation of protein secretion| |positive regulation of peptide secretion| |vesicle organization| |establishment of organelle localization| |Golgi vesicle transport| |positive regulation of secretion by cell| |positive regulation of protein transport| |positive regulation of secretion| |positive regulation of establishment of protein localization| |regulation of protein secretion| |regulation of peptide secretion| |organelle localization| |Golgi membrane| |regulation of protein transport| |regulation of peptide transport| |regulation of establishment of protein localization| |regulation of secretion by cell| |regulation of secretion| |zinc ion binding| |membrane organization| |endoplasmic reticulum membrane| |positive regulation of transport| |intracellular protein transport| |regulation of protein localization| |chemical homeostasis| |protein transport| |intracellular transport| |peptide transport| |protein-containing complex assembly| |amide transport| |cellular protein localization| |cellular macromolecule localization| |establishment of protein localization| |homeostatic process| |establishment of localization in cell| |nitrogen compound transport| |protein-containing complex subunit organization| |regulation of transport| |vesicle-mediated transport| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp226|Cerivastatin 0.15μM R05 exp226]]|-1.84| |[[:results:exp179|Combretastatin A4 0.002 to 0.003μM day4 R04 exp179]]|1.9| |[[:results:exp407|Thapsigargin 0.005μM R07 exp407]]|2.35| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 15633 * **Expression level (log2 read counts)**: 5.39 {{:chemogenomics:nalm6 dist.png?nolink |}}